NIH invites pediatric cohort samples for sequencing and other molecular analyses to uncover the genetic basis of childhood cancers and congenital anomalies, with data shared through Kids First.
Funder: National Institutes of Health
Due Dates: December 11, 2026 (Submissions open) | January 11, 2027 (Application deadline, 5:00 p.m. applicant local time)
Funding Amounts: Sequencing resource access only (no funds awarded), for up to 1 year; no cost sharing required
Summary: Provides sequencing and related genomic resources for pediatric cohorts to investigate childhood cancers, congenital anomalies, and shared genetic pathways.
Key Information: Samples must already exist, with consent permitting individual-level genomic and associated clinical and phenotypic data sharing.
The Gabriella Miller Kids First Pediatric Research Program offers access to NIH-supported genomic data generating centers through an X01 Resource Access Award. It supports existing pediatric cohorts investigating germline or somatic contributions to childhood cancers, the genetic causes of congenital anomalies, and connections between congenital anomalies and cancer risk. The initiative is administered by the Common Fund on behalf of DPCPSI, with a cross-NIH team led by NCI and NICHD.
Projects may request whole-genome, exome, transcriptome, and epigenomic sequencing of tumors or affected tissue. Long-read and clinical-grade sequencing require justification. Proteomics, and metabolomics for cancer tumors, may be accommodated with justification and availability. Generated data and associated clinical and phenotypic information will join the Kids First Data Resource to support cross-disease research, genetic discovery, and improved prevention, diagnosis, and treatment.